flurbiprofen has been researched along with Osteoarthritis in 35 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
Osteoarthritis: A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A comparative study was conducted to evaluate the therapeutic efficacy of diclofenac sodium and flurbiprofen both non-steroidal anti-inflammatory drugs (NSAIDS) in osteoarthritis." | 9.08 | Comparative study of diclofenac sodium and flurbiprofen in osteoarthritis. ( Ali, M; Shaikh, KA; Sharafatullah, T, 1996) |
| "A six week, double-blind, randomized, parallel group, multicentre study was conducted in 85 patients with osteoarthritis of the knee and hip to compare the efficacy, tolerability, and safety of Flurbiprofen-SR 200 mg with Diclofenac Sodium-SR 100 mg." | 9.07 | Double-blind randomized controlled trial of flurbiprofen-SR (ANSAID-SR) and diclofenac sodium-SR (Voltaren-SR) in the treatment of osteoarthritis. ( Bellamy, N; Bensen, WG; Ford, PM; Huang, SH; Lang, JY, 1992) |
| "The analgesic efficacy of flurbiprofen (Ansaid, Upjohn) and aspirin were compared in a 12-week, double-blind, randomized, parallel, multicenter study of 147 patients with osteoarthritis of the knee." | 9.06 | Treatment of osteoarthritis of the knee. A comparison of flurbiprofen and aspirin. ( Brinn, EL; Lamborn, KR; Lomen, PL; Porter, GH; Turner, LF, 1986) |
| "In this double-blind, randomized trial involving 143 patients with osteoarthritis of the hip and/or knee, the efficacy and safety of twice-daily dosing with flurbiprofen (Ansaid, Upjohn), which has a half-life of 5." | 9.06 | Double-blind comparison of flurbiprofen and sulindac for the treatment of osteoarthritis. ( Brown, BL; Hearron, MS; Johnson, JH, 1986) |
| "Seventy-four patients were enrolled in this double-blind, randomized single-center study to evaluate the therapeutic effectiveness of 50 mg tid regimens of flurbiprofen or diclofenac sodium in patients with osteoarthritis of the knee." | 9.06 | Flurbiprofen versus diclofenac for the treatment of osteoarthritis of the knee. ( Atra, E; Brown, BL; Metz, CA; Teoh, K, 1990) |
| "Flurbiprofen and ibuprofen, two propionic acid derivatives with anti-inflammatory and analgesic activity, were compared in a double-blind multiclinic study in 195 patients with osteoarthritis of the peripheral joints." | 9.04 | Response of osteoarthritis to ibuprofen or flurbiprofen. ( Ehrlich, GE; Giansiracusa, J; Gray, J; Mena, HR; Ward, J, 1976) |
| "Flurbiprofen, a phenylalkanoic acid derivative, is a non-steroidal anti-inflammatory, antipyretic, analgesic agent advocated for use in rheumatoid arthritis, degenerative joint disease, ankylosing spondylitis and allied conditions." | 8.76 | Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1979) |
| "The purpose of this study is to compare the efficacy and safety of pharmacotherapies for chronic pain due to osteoarthritis (OA) between a group with duloxetine (DLX) and S-flurbiprofen plaster (SFPP) (the SFPP group) and a group with DLX and conventional non-steroidal anti-inflammatory drugs (NSAIDs) (the control group)." | 8.12 | Comparison of efficacy and safety in the combination therapies of duloxetine and S-flurbiprofen plaster, and of duloxetine and conventional NSAIDs for chronic pain in patients with osteoarthritis (OASIS DUAL study). ( Koyama, K, 2022) |
| "The potential antinociceptive effects of the S(+)- and R(-)-enantiomers of flurbiprofen (SFB and RFB, respectively) were investigated when given intravenously to rats using the pain-induced functional impairment model in the rat (PIFIR), an animal model of arthritic pain." | 7.70 | Analysis of antinociceptive effects of flurbiprofen enantiomers in a rat model of arthritic pain. ( Cabré, F; Díaz, MI; Domínguez, AM; García, ML; Hernández, GP; López-Muñoz, FJ; Mauleón, D; Ventura, R, 2000) |
| "The safety of flurbiprofen (Ansaid, Upjohn) was assessed after pooling data on kidney and liver function collected from nine separate phase III clinical trials involving 1,677 patients (941 receiving flurbiprofen and 736 receiving comparison drugs) with ankylosing spondylitis, osteoarthritis, or rheumatoid arthritis." | 7.67 | Safety of flurbiprofen in the treatment of ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis. A summary of liver and kidney assay data. ( Lamborn, KR; Lomen, PL; Turner, LF, 1986) |
| "The prostaglandin E (PGE) level in the knee joint fluid was determined by radioimmunoassay before and after anti-inflammatory therapy with flurbiprofen in 8 patients with rheumatoid arthritis (RA) and 4 patients with osteoarthritis (OA)." | 7.66 | Change of prostaglandin E level in joint fluids after treatment with flurbiprofen in patients with rheumatoid arthritis and osteoarthritis. ( Ohuchi, K; Rikimaru, A; Tokunaga, M; Tsurufuji, S; Wakamatsu, E; Yoshizawa, S, 1981) |
| " The majority of drug-related adverse events (AEs) included mild dermatitis at the application sites and occurred in 46." | 6.82 | The Long-Term Safety of S-Flurbiprofen Plaster for Osteoarthritis Patients: An Open-Label, 52-Week Study. ( Hoshino, Y; Matsumoto, H; Matsushita, I; Otsuka, N; Yataba, I, 2016) |
| "A comparative study was conducted to evaluate the therapeutic efficacy of diclofenac sodium and flurbiprofen both non-steroidal anti-inflammatory drugs (NSAIDS) in osteoarthritis." | 5.08 | Comparative study of diclofenac sodium and flurbiprofen in osteoarthritis. ( Ali, M; Shaikh, KA; Sharafatullah, T, 1996) |
| "A six week, double-blind, randomized, parallel group, multicentre study was conducted in 85 patients with osteoarthritis of the knee and hip to compare the efficacy, tolerability, and safety of Flurbiprofen-SR 200 mg with Diclofenac Sodium-SR 100 mg." | 5.07 | Double-blind randomized controlled trial of flurbiprofen-SR (ANSAID-SR) and diclofenac sodium-SR (Voltaren-SR) in the treatment of osteoarthritis. ( Bellamy, N; Bensen, WG; Ford, PM; Huang, SH; Lang, JY, 1992) |
| "Seventeen patients with primary osteoarthritis of the knee were evaluated with respect to the severity and clinical importance of pain, stiffness and physical function during the conduct of a double-blind randomized controlled trial of flurbiprofen SR versus diclofenac sodium SR using the WOMAC Osteoarthritis Index." | 5.07 | Relationship between severity and clinical importance of symptoms in osteoarthritis. ( Bellamy, N; Campbell, J; Wells, G, 1991) |
| "Seventy-four patients were enrolled in this double-blind, randomized single-center study to evaluate the therapeutic effectiveness of 50 mg tid regimens of flurbiprofen or diclofenac sodium in patients with osteoarthritis of the knee." | 5.06 | Flurbiprofen versus diclofenac for the treatment of osteoarthritis of the knee. ( Atra, E; Brown, BL; Metz, CA; Teoh, K, 1990) |
| "A double-blind cross-over study was undertaken comparing the analgesic nefopam with the NSAID flurbiprofen in the treatment of osteoarthritis of the knees." | 5.06 | A comparison of nefopam and flurbiprofen in the treatment of osteoarthrosis. ( Haslock, I; Rhind, V; Stamp, J, 1989) |
| "In this double-blind, randomized trial involving 143 patients with osteoarthritis of the hip and/or knee, the efficacy and safety of twice-daily dosing with flurbiprofen (Ansaid, Upjohn), which has a half-life of 5." | 5.06 | Double-blind comparison of flurbiprofen and sulindac for the treatment of osteoarthritis. ( Brown, BL; Hearron, MS; Johnson, JH, 1986) |
| "The analgesic efficacy of flurbiprofen (Ansaid, Upjohn) and aspirin were compared in a 12-week, double-blind, randomized, parallel, multicenter study of 147 patients with osteoarthritis of the knee." | 5.06 | Treatment of osteoarthritis of the knee. A comparison of flurbiprofen and aspirin. ( Brinn, EL; Lamborn, KR; Lomen, PL; Porter, GH; Turner, LF, 1986) |
| "Forty patients with osteoarthrosis or rheumatoid arthritis were entered in a 4-week double-blind trial to compare the efficacy, safety and tolerance of a flurbiprofen 100 mg suppository formulation with indomethacin 100 mg suppositories." | 5.05 | A double-blind comparison of flurbiprofen and indomethacin suppositories in the treatment of osteoarthrosis and rheumatoid disease. ( De Moor, M; Ooghe, R, 1981) |
| "Flurbiprofen and ibuprofen, two propionic acid derivatives with anti-inflammatory and analgesic activity, were compared in a double-blind multiclinic study in 195 patients with osteoarthritis of the peripheral joints." | 5.04 | Response of osteoarthritis to ibuprofen or flurbiprofen. ( Ehrlich, GE; Giansiracusa, J; Gray, J; Mena, HR; Ward, J, 1976) |
| "Flurbiprofen, a phenylalkanoic acid derivative, is a non-steroidal anti-inflammatory, antipyretic, analgesic agent advocated for use in rheumatoid arthritis, degenerative joint disease, ankylosing spondylitis and allied conditions." | 4.76 | Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1979) |
| "The purpose of this study is to compare the efficacy and safety of pharmacotherapies for chronic pain due to osteoarthritis (OA) between a group with duloxetine (DLX) and S-flurbiprofen plaster (SFPP) (the SFPP group) and a group with DLX and conventional non-steroidal anti-inflammatory drugs (NSAIDs) (the control group)." | 4.12 | Comparison of efficacy and safety in the combination therapies of duloxetine and S-flurbiprofen plaster, and of duloxetine and conventional NSAIDs for chronic pain in patients with osteoarthritis (OASIS DUAL study). ( Koyama, K, 2022) |
| " Two hundred patients presenting with classic rheumatic diseases (osteoarthritis, n = 50; rheumatoid arthritis, n = 130; ankylosing spondylitis, n = 20) were given a daily dose of 200 mg sustained-release flurbiprofen (flurbiprofen SR)." | 3.70 | Six-month prospective study to monitor the treatment of rheumatic diseases with sustained-release flurbiprofen. ( Miceková, D; Rovenský, J, 2000) |
| "The potential antinociceptive effects of the S(+)- and R(-)-enantiomers of flurbiprofen (SFB and RFB, respectively) were investigated when given intravenously to rats using the pain-induced functional impairment model in the rat (PIFIR), an animal model of arthritic pain." | 3.70 | Analysis of antinociceptive effects of flurbiprofen enantiomers in a rat model of arthritic pain. ( Cabré, F; Díaz, MI; Domínguez, AM; García, ML; Hernández, GP; López-Muñoz, FJ; Mauleón, D; Ventura, R, 2000) |
| " Flurbiprofen (Ansaid) is a new NSAID for the treatment of rheumatoid arthritis and osteoarthritis." | 3.68 | Nonsteroidal antiinflammatory drug desensitization using flurbiprofen (Ansaid) ( Brown, JS; Douglas, DM; Ward, L, 1993) |
| "The safety of flurbiprofen (Ansaid, Upjohn) was assessed after pooling data on kidney and liver function collected from nine separate phase III clinical trials involving 1,677 patients (941 receiving flurbiprofen and 736 receiving comparison drugs) with ankylosing spondylitis, osteoarthritis, or rheumatoid arthritis." | 3.67 | Safety of flurbiprofen in the treatment of ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis. A summary of liver and kidney assay data. ( Lamborn, KR; Lomen, PL; Turner, LF, 1986) |
| "The prostaglandin E (PGE) level in the knee joint fluid was determined by radioimmunoassay before and after anti-inflammatory therapy with flurbiprofen in 8 patients with rheumatoid arthritis (RA) and 4 patients with osteoarthritis (OA)." | 3.66 | Change of prostaglandin E level in joint fluids after treatment with flurbiprofen in patients with rheumatoid arthritis and osteoarthritis. ( Ohuchi, K; Rikimaru, A; Tokunaga, M; Tsurufuji, S; Wakamatsu, E; Yoshizawa, S, 1981) |
| " The majority of drug-related adverse events (AEs) included mild dermatitis at the application sites and occurred in 46." | 2.82 | The Long-Term Safety of S-Flurbiprofen Plaster for Osteoarthritis Patients: An Open-Label, 52-Week Study. ( Hoshino, Y; Matsumoto, H; Matsushita, I; Otsuka, N; Yataba, I, 2016) |
| "Data from 58 premarketing studies of the nonsteroidal antiinflammatory drug flurbiprofen were pooled for analyses of adverse drug reactions (ADRs)." | 2.67 | Clinical safety of flurbiprofen. ( Assenzo, JR; Brooks, CD; Defesche, CL; Johnson, JH; Linet, OI; Schellenberg, D; Teoh, KW; Turner, LF, 1990) |
| " Side-effects were similar in nature to those of other drugs in this group and no correlation in their frequency or severity with the dosage of flurbiprofen was found." | 2.66 | A long-term study of flurbiprofen in rheumatological disorders: II. Osteoarthrosis. ( Busson, M, 1986) |
| "Thirty patients with osteoarthrosis of the hip were studied in a double-blind crossover comparison of 150 mg flurbiprofen daily and 75 mg indomethacin daily, each drug being given for 2 weeks separated by a wash-out period of 1 week on placebo." | 2.64 | A double-blind comparative study of 150 mg flurbiprofen daily and 75 mg indomethacin daily in the treatment of osteoarthrosis of the hip joint. ( Frank, O, 1977) |
| "Flurbiprofen has been shown to be effective in relieving symptoms in the degenerative and inflammatory arthritides and side-effects have not proved a problem." | 1.26 | A long-term assessment of flurbiprofen. ( Marsh, BD; Sheldrake, FE; Webber, JM, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (65.71) | 18.7374 |
| 1990's | 7 (20.00) | 18.2507 |
| 2000's | 2 (5.71) | 29.6817 |
| 2010's | 2 (5.71) | 24.3611 |
| 2020's | 1 (2.86) | 2.80 |
| Authors | Studies |
|---|---|
| Koyama, K | 1 |
| Otsuka, N | 2 |
| Yataba, I | 2 |
| Matsushita, I | 2 |
| Matsumoto, H | 2 |
| Hoshino, Y | 2 |
| Terada, Y | 1 |
| Banović, D | 1 |
| Nesović, B | 1 |
| Famaey, JP | 1 |
| Ginsberg, F | 1 |
| De Moor, M | 2 |
| Ooghe, R | 1 |
| Pavelka, K | 1 |
| Susta, A | 1 |
| Tokunaga, M | 1 |
| Ohuchi, K | 1 |
| Yoshizawa, S | 1 |
| Tsurufuji, S | 1 |
| Rikimaru, A | 1 |
| Wakamatsu, E | 1 |
| Douglas, DM | 1 |
| Ward, L | 1 |
| Brown, JS | 1 |
| Shaikh, KA | 1 |
| Ali, M | 1 |
| Sharafatullah, T | 1 |
| Dhavse, VV | 1 |
| Parmar, DV | 1 |
| Devarajan, PV | 1 |
| Rovenský, J | 1 |
| Miceková, D | 1 |
| López-Muñoz, FJ | 1 |
| Ventura, R | 1 |
| Díaz, MI | 1 |
| Hernández, GP | 1 |
| Domínguez, AM | 1 |
| García, ML | 1 |
| Cabré, F | 1 |
| Mauleón, D | 1 |
| Sheldrake, FE | 1 |
| Webber, JM | 1 |
| Marsh, BD | 1 |
| Innes, EH | 1 |
| Doury, P | 1 |
| Pattin, S | 1 |
| Cardoe, N | 1 |
| Frank, O | 1 |
| Brogden, RN | 1 |
| Heel, RC | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Bhasin, RC | 1 |
| Bhuttani, P | 1 |
| Krishnan, CV | 1 |
| Sachdev, S | 1 |
| Mena, HR | 1 |
| Ehrlich, GE | 1 |
| Giansiracusa, J | 1 |
| Ward, J | 1 |
| Gray, J | 1 |
| Bellamy, N | 2 |
| Bensen, WG | 1 |
| Ford, PM | 1 |
| Huang, SH | 1 |
| Lang, JY | 1 |
| Wells, G | 1 |
| Campbell, J | 1 |
| Brooks, CD | 1 |
| Linet, OI | 1 |
| Schellenberg, D | 1 |
| Turner, LF | 3 |
| Defesche, CL | 1 |
| Teoh, KW | 1 |
| Johnson, JH | 2 |
| Assenzo, JR | 1 |
| Atra, E | 1 |
| Metz, CA | 1 |
| Brown, BL | 2 |
| Teoh, K | 1 |
| Stamp, J | 1 |
| Rhind, V | 1 |
| Haslock, I | 1 |
| Boston, PF | 1 |
| Grayson, MF | 1 |
| Hazelman, BL | 1 |
| Matts, SG | 1 |
| Coutellier, P | 1 |
| Franchimont, P | 1 |
| Mortier, G | 1 |
| Rosselle, N | 1 |
| Goie The, HS | 1 |
| Di Matteo, L | 1 |
| Evangelista, L | 1 |
| Bosica, D | 1 |
| Renzetti, A | 1 |
| D'Incecco, V | 1 |
| Consoli, G | 1 |
| Busson, M | 1 |
| Hearron, MS | 1 |
| Perpignano, G | 1 |
| Uras, R | 1 |
| Ibba, G | 1 |
| Lomen, PL | 2 |
| Lamborn, KR | 2 |
| Porter, GH | 1 |
| Brinn, EL | 1 |
| Bassiouni, M | 1 |
1 review available for flurbiprofen and Osteoarthritis
| Article | Year |
|---|---|
Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Interactions; Flurbipr | 1979 |
25 trials available for flurbiprofen and Osteoarthritis
| Article | Year |
|---|---|
A minimal impact of long-term S-flurbiprofen plaster application on kidney function in osteoarthritis patients.
Topics: Administration, Cutaneous; Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Flurbiprofen; Huma | 2017 |
The Long-Term Safety of S-Flurbiprofen Plaster for Osteoarthritis Patients: An Open-Label, 52-Week Study.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Dermatitis, Contact; Female; | 2016 |
[Comparative study of piroxicam and flurbiprofen in the therapy of osteoarthrosis].
Topics: Adult; Aged; Anti-Inflammatory Agents; Clinical Trials as Topic; Double-Blind Method; Female; Flurbi | 1983 |
Treatment of osteoarthrosis of the spine: a comparison of flurbiprofen and diclofenac.
Topics: Adult; Aged; Clinical Trials as Topic; Diclofenac; Double-Blind Method; Drug Administration Schedule | 1983 |
A double-blind comparison of flurbiprofen and indomethacin suppositories in the treatment of osteoarthrosis and rheumatoid disease.
Topics: Adult; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Female; Flurbiprofen; H | 1981 |
[Flurbiprofen (Flugalin) - a new non-steroidal antirheumatic agent from the propionic acid derivative series].
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Female; Flurbiprofen; Humans; Male; Middle Aged; Os | 1982 |
Comparative study of diclofenac sodium and flurbiprofen in osteoarthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Flurbiprofen; Humans; Male; Osteoarthri | 1996 |
High-performance thin-layer chromatographic determination of flurbiprofen in plasma.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Capsules; Chromatography, Thin Layer; Flurbiprofen; | 1997 |
Efficacy and tolerance of flurbiprofen in the elderly using liquid and tablet formulations.
Topics: Aged; Aging; Dosage Forms; Female; Flurbiprofen; Hip Joint; Humans; Male; Osteoarthritis; Palliative | 1977 |
Comparative study of the effectiveness of flurbiprofen given twice or 3-times daily.
Topics: Adult; Aged; Drug Administration Schedule; Female; Flurbiprofen; Hip Joint; Humans; Male; Middle Age | 1977 |
A double-blind crossover study to compare the efficacy of three dosage levels of flurbiprofen in the treatment of rheumatoid disease and osteoarthrosis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Clinical Trials as Topic; Dose-Response Relationship, Drug; Doub | 1977 |
A double-blind comparative study of 150 mg flurbiprofen daily and 75 mg indomethacin daily in the treatment of osteoarthrosis of the hip joint.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Flurbiprofen; Hip Joint; Humans; | 1977 |
Flurbiprofen and phenylbutazone in rheumatoid arthritis and osteoarthrosis: a double-blind study.
Topics: Adult; Arthritis, Rheumatoid; Double-Blind Method; Female; Flurbiprofen; Humans; Male; Osteoarthriti | 1979 |
Response of osteoarthritis to ibuprofen or flurbiprofen.
Topics: Aged; Clinical Trials as Topic; Drug Evaluation; Female; Flurbiprofen; Humans; Ibuprofen; Male; Midd | 1976 |
Double-blind randomized controlled trial of flurbiprofen-SR (ANSAID-SR) and diclofenac sodium-SR (Voltaren-SR) in the treatment of osteoarthritis.
Topics: Adolescent; Adult; Aged; Diclofenac; Double-Blind Method; Flurbiprofen; Humans; Middle Aged; Osteoar | 1992 |
Relationship between severity and clinical importance of symptoms in osteoarthritis.
Topics: Clinical Trials as Topic; Diclofenac; Double-Blind Method; Female; Flurbiprofen; Humans; Male; Middl | 1991 |
Clinical safety of flurbiprofen.
Topics: Adult; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Digestive System; Female; Flurbipro | 1990 |
Flurbiprofen versus diclofenac for the treatment of osteoarthritis of the knee.
Topics: Adult; Aged; Diclofenac; Double-Blind Method; Female; Flurbiprofen; Humans; Knee Joint; Male; Middle | 1990 |
Flurbiprofen.
Topics: Adult; Arthritis, Rheumatoid; Clinical Trials as Topic; Flurbiprofen; Gastrointestinal Diseases; Hum | 1989 |
A comparison of nefopam and flurbiprofen in the treatment of osteoarthrosis.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Flurbiprofen; Humans; Male; Middle Aged; Nefo | 1989 |
Flurbiprofen sustained-release in OA knee.
Topics: Adult; Aged; Aged, 80 and over; Delayed-Action Preparations; Female; Flurbiprofen; Humans; Knee Join | 1988 |
A long-term study of flurbiprofen in rheumatological disorders: II. Osteoarthrosis.
Topics: Adult; Aged; Clinical Trials as Topic; Drug Therapy, Combination; Female; Flurbiprofen; Humans; Male | 1986 |
Double-blind comparison of flurbiprofen and sulindac for the treatment of osteoarthritis.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Flurbiprofen; H | 1986 |
[Double-blind cross-over comparison of flurbiprofen and indomethacin in osteoarthritis of the knee and hip].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Flurbiprofen; Hip Jo | 1986 |
Treatment of osteoarthritis of the knee. A comparison of flurbiprofen and aspirin.
Topics: Adult; Aged; Aspirin; Drug Evaluation; Female; Flurbiprofen; Humans; Knee Joint; Male; Middle Aged; | 1986 |
9 other studies available for flurbiprofen and Osteoarthritis
| Article | Year |
|---|---|
Comparison of efficacy and safety in the combination therapies of duloxetine and S-flurbiprofen plaster, and of duloxetine and conventional NSAIDs for chronic pain in patients with osteoarthritis (OASIS DUAL study).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chronic Pain; Drug-Related Side Effects and Adverse Reactio | 2022 |
Change of prostaglandin E level in joint fluids after treatment with flurbiprofen in patients with rheumatoid arthritis and osteoarthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Female; Flurbiprofen; Humans; Leukocyte Count; Male; Middle Aged | 1981 |
Nonsteroidal antiinflammatory drug desensitization using flurbiprofen (Ansaid)
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Cross Reactions; Des | 1993 |
Six-month prospective study to monitor the treatment of rheumatic diseases with sustained-release flurbiprofen.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Delayed-Act | 2000 |
Analysis of antinociceptive effects of flurbiprofen enantiomers in a rat model of arthritic pain.
Topics: Analgesics; Animals; Area Under Curve; Arthritis; Disease Models, Animal; Dose-Response Relationship | 2000 |
A long-term assessment of flurbiprofen.
Topics: Arthritis; Arthritis, Rheumatoid; Bone Diseases; Female; Flurbiprofen; Humans; Joint Diseases; Male; | 1977 |
[Non-steroid anti-inflammatory drugs and beta-endorphin].
Topics: Arthritis, Rheumatoid; beta-Endorphin; Endorphins; Female; Flurbiprofen; Humans; Male; Osteoarthriti | 1985 |
Safety of flurbiprofen in the treatment of ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis. A summary of liver and kidney assay data.
Topics: Alanine Transaminase; Alkaline Phosphatase; Arthritis, Rheumatoid; Aspartate Aminotransferases; Aspi | 1986 |
Open study of flurbiprofen in the treatment of osteoarthritis of the knee.
Topics: Female; Flurbiprofen; Humans; Knee Joint; Male; Middle Aged; Osteoarthritis; Propionates | 1985 |